Chemical | 13 August 2026
PTT Global Chemical stands firm and targets new growth chapter
As petrochemicals, specialty & green & bio take center stage
As petrochemicals, specialty & green & bio take center stage
Lance will retire as president and CEO after 14 years at the helm and move to executive chair of the board in a transitional role
.jpg)
Consolidated PAT more than doubled year-on-year to Rs. 61 crore, while revenue from operations climbed 37.7% to Rs. 1,065 crore
The company secured Rs. 34 billion in new orders during the quarter
The situation is fully under control, and normal production operations have been completely restored
The center is designed as both a showroom and a collaborative development hub for automotive manufacturers
ORLEN generated PLN 15.2 billion in operating cash flow during the quarter
The acquisition adds engineered pumping technologies designed for difficult fluid-handling environments
Floragenist rose supports skin radiance for a “diamond skin” effect
How intelligent bagging and palletizing solutions are solving the sector's toughest packaging challenges
The new facility integrates advanced process controls, digital automation and intelligent manufacturing systems to improve product consistency, operational efficiency and supply reliability
The project highlights how tightly integrated industrial sites can accelerate the shift to lower-carbon production
The company said it plans to double its IIL Crop Solutions (ICS) plots from the current 36, covering rice, cotton, chilli and soybean across 14 states
Q1 FY2026-27 started on a strong note as we made solid progress on our strategic priorities
Vietnam's success in becoming an additional sourcing point in supply chains stems from a combination of trade policies and infrastructure readiness
This year’s theme, “Staying Resilient in a New Age World,” puts the spotlight on how businesses can navigate rapidly changing markets, technological disruption and an increasingly interconnected global economy
BASF holds co-exclusive rights to market and sell Bemotrizinol during the FDA’s 18-month exclusivity period
Consolidated EBITDA surged 62.16 per cent year-on-year to Rs. 19.80 crore from Rs. 12.21 crore in Q1 FY26
The capital will be used specifically for the renovation and expansion of the leased iron phosphate production assets
Subscribe to our newsletter & stay updated.
